Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-03-10 @ 7:23 PM
Study NCT ID:
NCT00290693
Status:
COMPLETED
Last Update Posted:
2017-12-02
First Post:
2006-02-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
Sponsor:
University of Miami
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20030652
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None